ELV
ELV
Below: live stock price for ELV (ELV), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.
ELV (ELV) is a Healthcare company based in United States. Operating in Healthcare Plans, it employs about 96,129 people. Over the past year ELV traded between 274.84 and 436.24 USD. It currently yields 1.60% in dividends.
- Prev close
- $428.26
- Volume (24h)
- —
- Market cap
- —
- Currency
- USD
Score
50/ 100 · Mixed
- Value68
- Quality35
- Momentum47
- Growth24
- Risk79
- Dividend55
- Liquidity44
Composite of public market data. Informational only — not investment advice.
Trend projection
Where the recent trend points if it continues.
- +5 bars
- 428.6687 +0.50%
- +20 bars
- 431.6023 +1.18%
- +60 bars
- 432.7426 +1.45%
- +120 bars
- 432.7845 +1.46%
Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: ±0.0265 USD.
Interpretation
Composite signals look mixed. Strength: risk profile with weakness: growth. Price sits near the upper third of the recent range, trend is sloping upward.
Descriptive observation — not investment advice.
Score breakdown
Raw values behind each pillar so you can see what the composite is reading.
- Value68/100
Value looks solid — driven by P/E (18.96).
P/E:18.96P/B:2.08PEG:1.4 - Quality35/100
Quality looks weak — driven by Gross margin (25.99%).
ROE:11.13%ROA:3.83%Profit margin:2.47%Gross margin:25.99% - Momentum47/100
Momentum looks mixed — driven by 52w change (20.95%).
52w change:20.95% - Growth24/100
Growth looks fragile — driven by Earnings growth (-13.10%).
Revenue growth:1.40%Earnings growth:-13.10% - Risk79/100
Risk looks strong — driven by Debt / equity (68.95).
Beta:0.71Debt / equity:68.95Short interest:2.51% - Dividend55/100
Dividend looks mixed — driven by Payout ratio (30.37%).
Dividend yield:1.60%Payout ratio:30.37% - Liquidity44/100
Liquidity looks weak — driven by Current ratio (1.52).
Current ratio:1.52Quick ratio:1.37
Derived from public market data — informational, not investment advice.
Price report
How this asset has actually moved over the last 251 days.
Where the price sits between the window low and high.
- Volatility (annualised)
- 35.5%
- Max drawdown
- -26.5%
- Below period high
- -2.2%
- Best day
- +7.62%
- Worst day
- -14.33%
- Up days
- 52%
- Current streak
- 2 down
- Typical day swing
- 2.8%
- Volume vs average
- -5%
Spread of returns. Higher means larger swings in both directions.
Worst peak-to-trough fall inside the window.
Current price against the highest point in the window.
Share of days that closed above the one before.
Average high-to-low spread within a single day.
Last 10 days against the whole window.
Descriptive statistics over past prices — not a forecast and not investment advice.
Reference levels
Fibonacci retracements and extensions across the recent range.
Reference only — not investment advice.
These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.
Levels derived from: 435.5 high → 362.98 low · 60 bars
- ResistanceFib +161.8% extensionnot reached552.8373 USD+29.61% from current
- ResistanceFib +100% extensionnot reached508.02 USD+19.10% from current
- ResistanceFib +61.8% extensionnot reached480.3174 USD+12.60% from current
- ResistanceFib +27.2% extensionnot reached455.2254 USD+6.72% from current
- Current426.555 USD
- SupportFib 23.6% retracementNearesttested 7×418.3853 USD-1.92% from current
- SupportFib 38.2% retracementtested 11×407.7974 USD-4.40% from current
- SupportFib 50% midpointtested 22×399.24 USD-6.40% from current
- SupportFib 61.8% retracementtested 9×390.6826 USD-8.41% from current
- SupportFib 78.6% retracementtested 8×378.4993 USD-11.27% from current
- SupportFib −27.2% extensionnot reached343.2546 USD-19.53% from current
- SupportFib −61.8% extensionnot reached318.1627 USD-25.41% from current
- SupportFib −100% extensionnot reached290.46 USD-31.91% from current
How to read this
We take the highest and lowest price of the last 60 bars and cut the gap between them at the classic Fibonacci ratios (23.6%, 38.2%, 50%, 61.8%, 78.6%), plus extensions beyond both ends.
“Tested N×” counts how many of those 60 bars actually traded through the level. A level price has crossed many times is one the market has repeatedly agreed on; a level at 0 is pure geometry the price has never reached.
This is a map of where trading has already happened — not a forecast and not a signal. Price moves through these levels all the time.
Financials
- 52w high
- $436.24
- 52w low
- $274.84
- 52w change
- 20.95%
- Day high
- $435.50
- Day low
- $425.00
- P/E (TTM)
- 18.96
- Forward P/E
- 14.53
- PEG
- 1.4
- Price / Book
- 2.08
- Beta (5Y)
- 0.71
- Enterprise value
- 86.97B
- EV / Revenue
- 0.43
- EV / EBITDA
- 10.45
- EPS (TTM)
- $22.69
- Forward EPS
- $29.60
- Dividend yield
- 1.60%
- Dividend rate
- $6.88
- Payout ratio
- 30.37%
- Revenue (TTM)
- 201.11B
- EBITDA
- 8.32B
- Free cash flow
- 4.31B
- Total cash
- 37.51B
- Total debt
- 31.04B
- Debt / Equity
- 68.95
- Current ratio
- 1.52
- Quick ratio
- 1.37
- Profit margin
- 2.47%
- Gross margin
- 25.99%
- Return on assets
- 3.83%
- Return on equity
- 11.13%
- Shares outstanding
- 216.87M
- Float
- 216.37M
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Analyst & Risk
- Beta (vs S&P 500)
- 0.71
- less volatile
- 52-week change
- 20.95%
- Short % of float
- 2.51%
- Short ratio (days)
- 3.9
- Debt / Equity
- 68.95
- very high leverage
- Current ratio
- 1.52
- Quick ratio
- 1.37
- ROE
- 11.13%
- ROA
- 3.83%
- PEG ratio
- 1.4
- fair
- EV / Revenue
- 0.43
- EV / EBITDA
- 10.45
- Revenue growth
- 1.40%
- Earnings growth
- -13.10%
- EBITDA
- 8.32B
- Free cash flow
- 4.31B
- Total cash
- 37.51B
- Total debt
- 31.04B
- Insider holdings
- 0.19%
- Institutional
- 94.03%
Recent rating changes
- 2026-10-12GuggenheimBuy → Buymain
- 2026-10-07BarclaysOverweight → Overweightmain
- 2026-07-17BernsteinOutperform → Outperformmain
- 2026-07-17Leerink PartnersMarket Perform → Market Performmain
- 2026-07-16RBC CapitalSector Perform → Sector Performmain
- 2026-07-16Wells FargoOverweight → Overweightmain
- 2026-07-16GuggenheimBuy → Buymain
- 2026-07-16BarclaysOverweight → Overweightmain
Financial documents
- Corporate Changes & Voting Matters8-K2026-09-10
- Periodic Financial Reports10-Q2026-07-15
- Annual report of employee stock purchase11-K2026-06-17
- Corporate Changes & Voting Matters8-K2026-06-10
- Corporate Changes & Voting Matters8-K2026-05-13
- Corporate Changes & Voting Matters8-K2026-04-22
- Proxy StatementsDEFA14A2026-03-27
- Corporate Changes & Voting Matters8-K2026-03-10
- Corporate Changes & Voting Matters8-K2026-03-02
- Corporate Changes & Voting Matters8-K2026-02-26
- Periodic Financial Reports10-K2026-02-06
- Corporate Changes & Voting Matters8-K2026-01-28
Recent news
- Management Raised The Bar For CVS Health Stock; Does The Chart Agree?Trefis16h ago
- What Would It Take For Rising Medical Costs To Break UnitedHealth Stock?Trefis16h ago
- Is Elevance Health, Inc. (ELV) Outperforming Other Medical Stocks This Year?Zacks16h ago
- 3 US Dividend Stocks Worth Watching As Treasury Yields ClimbSimply Wall St.3d ago
- Where Could UnitedHealth's Next Growth Come From?Trefis3d ago
- Unveiling Elevance Health (ELV) Q3 Outlook: Wall Street Estimates for Key MetricsZacks3d ago
- Elevance Q3 Earnings Preview: Will Lower Premiums Weigh on Results?Zacks4d ago
- What Happened With UnitedHealth Stock This Week?Trefis4d ago
Related
Other assets in this category.
- 8306.TMitsubishi UFJ Financial Group, Inc.3,368 USD-3.16%
- 7203.TToyota Motor Corporation3,096 USD-0.19%
- 9984.TSoftBank Group Corp.4,549 USD-6.11%
- 6758.TSony Group Corporation3,937 USD-0.58%
- 6861.TKeyence Corporation80,750 USD-0.81%
- NVDANVIDIA Corporation217.09 USD+1.38%
- AAPLApple Inc.342.94 USD-0.15%
- GOOGLAlphabet Inc.344.18 USD+1.05%
Learn the terms
Live discussion
Sign in to join the discussion.
- No comments yet. Be the first.